Flagship Wealth Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Flagship Wealth Advisors's MRNA Position: Q3 2026 in Review
Flagship Wealth Advisors held its Moderna (MRNA) position steady in Q3 2026 at 185 shares worth $35.6K. The position accounts for 0.01% of the portfolio, ranked #297.
Flagship Wealth Advisors first reported a position in MRNA in Q4 2024 and has held it in 8 quarters since. 962 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Flagship Wealth Advisors held 185 shares of Moderna worth $35.6K as of Q3 2026.
- Flagship Wealth Advisors left its Moderna share count unchanged in Q3 2026.
- Moderna made up 0.01% of Flagship Wealth Advisors's portfolio in Q3 2026, its #297 holding.
- Flagship Wealth Advisors first reported a position in Moderna in Q4 2024 and has held it in 8 quarters since.
- 962 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Flagship Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.